FeaturesSignalPricingFounders
KV

Kairos Ventures

Venture CapitalActive

Kairos Ventures invests in ideas, patents, and businesses from the top universities and scientists.

Beverly Hills, United StatesFounded 2010kairosventures.com/
44
Investments
3
Exits
$500M
AUM
6.8%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Kairos Ventures.

Get started free

Investment Thesis & Strategy

Kairos Ventures invests in early-stage companies, including ideas and patents, originating from top universities and scientists across various sectors. They focus on backing innovative technologies and research with high growth potential.

Investment Activity

Deals per year over the last 5 years

2
2019
1
2020
8
2021
0
2022
1
2023

Portfolio Companies

Selected investments from their portfolio of 44 companies

V
VentureWell
Other · Growth, 2023
Active
C
Cellino
Biotech · Series A, 2021
Active
T
Tessera Therapeutics
Biotech · Series A, 2021
Active
K
Kytopen
Biotech · Series A, 2021
Active
E
Epirium Bio
Biotech · Series A, 2021
Active
X
Xilis
Biotech · Series A, 2021
Active
E
Enveda Biosciences
Biotech · Series A, 2021
Active
E
E-Therapeutics
Biotech · Series A, 2021
Active
R
ReNetX Bio
Biotech · Series A, 2021
Active
A
Aegle Therapeutics
Biotech · Series A, 2020
Active
L
Locus Biosciences
Biotech · Series A, 2019
Active
S
Sana Biotechnology
Biotech · Series A, 2019
Active

Notable Exits

CompanyTypeYearValue / Acquirer
LimeAcquisition2024
BirdIPO2021$2.3B
LyftIPO2019$24.3B

Frequently Asked Questions

Kairos Ventures focuses on Series A, Series B, Series C+ stage investments.

Related Investors